Back to funds
View filing
Nantahala Capital Management, LLC
hedge fundUpdated 22 days agoManaged by Nantahala Capital Management, Llc • Latest filing Q2 2026
Portfolio value
$3B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
54.8%
Weight of largest holdings
Annualized return
34.1%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $1.3B |
| Q2 2023 | $1B |
| Q3 2023 | $1.2B |
| Q4 2023 | $1.7B |
| Q1 2024 | $1.8B |
| Q2 2024 | $1.7B |
| Q3 2024 | $2B |
| Q4 2024 | $2.3B |
| Q1 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q3 2025 | $2.9B |
| Q4 2025 | $3B |
| Q1 2026 | $2.7B |
| Q2 2026 | $3B |
Top holdings
155 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | E ETHA ISHARES TR | $600.9M | 2.00M | 19.93% | — |
| 2 | P PEGA PELOTON INTERACTIVE INC | $97.2M | 16.44M | 3.22% | — |
| 3 | H HLF HERBALIFE LTD | $86.8M | 6.60M | 2.88% | — |
| 4 | V VTRS VIATRIS INC | $79.4M | 5.00M | 2.63% | — |
| 5 | B BCTF BANCORP INC DEL | $77.7M | 1.24M | 2.58% | — |
| 6 | E EW EDWARDS LIFESCIENCES CORP | $72.4M | 800.0K | 2.40% | — |
| 7 | S STT-PG SPDR SERIES TRUST | $63.3M | 400.0K | 2.10% | — |
| 8 | B BVS BIOVENTUS INC | $56.6M | 6.00M | 1.88% | — |
| 9 | H HGV HILTON GRAND VACATIONS INC | $56.3M | 1.07M | 1.87% | — |
| 10 | H HGV HILTON GRAND VACATIONS INC | $54.1M | 1.03M | 1.79% | — |
| 11 | S SVRA SAVARA INC | $43M | 6.98M | 1.43% | — |
| 12 | E ETON ETON PHARMACEUTICALS INC | $42.6M | 1.18M | 1.41% | — |
| 13 | A AMRX AMNEAL PHARMACEUTICALS INC | $39.3M | 2.27M | 1.30% | — |
| 14 | E EOLS EVOLUS INC | $38.9M | 5.60M | 1.29% | — |
| 15 | Q QUBT ETF SER SOLUTIONS | $36.9M | 223.0K | 1.22% | — |
| 16 | Q QURE UNIQURE NV | $36.8M | 800.0K | 1.22% | — |
| 17 | A AVTX AVALO THERAPEUTICS INC | $34.4M | 1.86M | 1.14% | — |
| 18 | L LBRX LB PHARMACEUTICALS INC | $34.2M | 1.05M | 1.13% | — |
| 19 | N NBIX NEUROCRINE BIOSCIENCES INC | $33.7M | 200.0K | 1.12% | — |
| 20 | P PRAX PRAXIS PRECISION MEDICINES I | $33.5M | 100.0K | 1.11% | — |